The MPNs include essential thrombocythemia (ET), polycythemia vera (PV) and primary myelofibrosis (PMF). A total of 18 patients have been enrolled in this open-label, single-arm, multicenter Phase II
According to FDA, all currently enrolled patients can continue receiving aldoxorubicin treatment, or comparator drugs, as per study protocols. Additionally, the company cannot enrol new patients until the
The new liquid formulation eliminates the need of reconstituting lyophilized powder with sterile water before adding the required dose of medicine to the infusion bag and administering to
The territory covers China including Mainland China, Taiwan, Hong Kong and Macau as well as other countries, including Thailand, Brazil and Russia. 3SBio president and CEO Dr Jing
Harvoni is a combination of the NS5A inhibitor ledipasvir (LDV) and the nucleotide analog polymerase inhibitor sofosbuvir (SOF) and is indicated to treat adults with chronic hepatitis C
The US Food and Drug Administration (FDA) approval of Trumenba is based on the demonstration of immune response, as measured by serum bactericidal activity against four serogroup B
The approval is based on positive data from the Phase III VIVID-DME and VISTA-DME trials and one open label single arm safety trial in Japanese patients (VIVID-Japan). During
Both the firms have not been disclosed financial details of the agreement. Aspen has agreed to specific annual commercial goals for Brinavess. Cardiome chief commercial officer Karim Lalji
The randomized, observer-blinded, dose-ranging trial will evaluate the safety and immunogenicity of the Seasonal Influenza VLP in 400 healthy adult subjects. The trial’s primary outcomes will be to
Teva’s Celecoxib is also indicated for the short-term management of moderate to severe acute pain in adults, in conditions such as musculoskeletal and/or soft tissue trauma including sprains,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.